This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Alere Inc (ALR): Today's Featured Health Services Winner

Alere ( ALR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 1.4%. By the end of trading, Alere rose 14 cents (0.8%) to $18.60 on heavy volume. Throughout the day, 1.7 million shares of Alere exchanged hands as compared to its average daily volume of 818,200 shares. The stock ranged in a price between $18.37-$18.72 after having opened the day at $18.53 as compared to the previous trading day's close of $18.46. Other companies within the Health Services industry that increased today were: Edap TMS ( EDAP), up 5.9%, Graymark Healthcare ( GRMH), up 5.1%, IVAX Diagnostics ( IVD), up 5.1%, and Concord Medical Services Holdings ( CCM), up 4.9%.

Alere Inc. develops and manufactures patient diagnosis, monitoring, and health management products and services for cardiology, infectious diseases, toxicology, diabetes, oncology, and women's health in the United States and internationally. Alere has a market cap of $1.47 billion and is part of the health care sector. Shares are down 20.7% year to date as of the close of trading on Thursday. Currently there are three analysts that rate Alere a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Alere as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally poor debt management.

On the negative front, Stereotaxis ( STXS), down 13.1%, Sun Healthcare Group ( SUNH), down 11%, Fonar Corporation ( FONR), down 9.7%, and LCA-Vision ( LCAV), down 9.2%, were all losers within the health services industry with UnitedHealth Group ( UNH) being today's health services industry loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs